Pinealon is a short synthetic tripeptide from the same Russian research group behind Epitalon and Semax, studied for neuroprotective and cellular-aging effects. Its proposed mechanism (direct gene-expression regulation rather than receptor binding) is a hypothesis largely specific to its originating research group and has not been independently replicated at scale.
Part of a family of short synthetic peptides (2-4 amino acids) developed by Vladimir Khavinson's research group, each targeted at a specific tissue/organ. The evidence base for this entire peptide family shares the same limitation: it's concentrated almost entirely within this one research lineage (largely the same institute, often the same handful of authors), is mostly preclinical (rodent, cell-culture) or small Russian human pilot work, and hasn't been independently replicated by unaffiliated Western labs in a way this research pass could verify. None of these compounds is FDA or EMA approved for human use anywhere.
Pinealon (Glu-Asp-Arg) is pitched as a neuroprotective/pineal-related peptide. Secondary reporting describes a PubMed-indexed study finding dose-dependent reduction of oxidative-stress-induced ROS accumulation in cultured cells, and a separate human study on synthetic peptides in elderly patients with chronic polymorbidity and organic brain syndrome. PMID 26390612 — this specific citation wasn't independently re-verified against the primary source (title/findings) in this research pass; treat with the same lower-confidence tier as other unverified citations in this batch until confirmed directly.
Neuroprotection, cognitive support, and cellular aging, primarily in the same body of Russian peptide-bioregulator research that produced Epitalon and Semax.
Its originating research group proposes it can cross cell and nuclear membranes to directly regulate gene expression, unlike most peptides which act via surface receptors — a hypothesis that remains largely confined to that research group's own publications.
No, it is not an approved drug and is sold for research use only.
There's a genuinely large body of it — over four decades and 700+ publications from the group behind it — but nearly all of it originates from Russian institutions, with limited independent replication elsewhere. Not fringe exactly, but not validated the way most Western-approved compounds are either.
Mostly animal studies — aged rats given Pinealon showed measurably better performance on maze-based learning and memory tasks. Real and specific, just not the same as human clinical trial data.
Same research family, same short-chain-peptide-as-tissue-regulator concept, different target — Epitalon is framed around general longevity and pineal hormone regulation broadly, Pinealon specifically around brain and cognitive tissue.
Looking for something specific, or placing a wholesale order? Send us a DM or email.